Clinical Trials in Colorado

Showing 9341-9360 of 13,761 trials

Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas

NCT01189864

The purpose of this study is to evaluate the efficacy of ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) as a method to increase the biomechanical and biochemical stability of the cornea by inducing additional cross-links within or between collagen fibers using UVA light and the photo- mediator riboflavin. The purpose of this study is to generate data for presentation at medical meetings and for peer-review publication. The data generated by this study will not be submitted to the FDA to support commercialization of these riboflavin drops.

KeratoconusEctasiaDegeneration

Cxlusa3,493 participantsStarted Feb 2010

Scottsdale, Arizona, United States • Laguna Hills, California, United States • San Diego, California, United States +13 more locations

COMPLETEDPhase 350 miles

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

NCT02581345

The purpose of the study is to evaluate efficacy, safety, and immunogenicity of a proposed adalimumab biosimilar (M923) and Humira in participants with moderate to severe chronic plaque-type psoriasis.

Chronic Plaque PsoriasisPsoriasis

Momenta Pharmaceuticals, Inc.572 participantsStarted Sep 2015

Beverly Hills, California, United States • Encino, California, United States • La Mesa, California, United States +87 more locations

Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

Find Trials by Condition in Colorado

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy

A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection

A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults

Sevelamer for Reducing Endotoxemia and Immune Activation

Early Weight-Bearing After Lapidus Arthrodesis

Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)

Post-Market Study of the Modular Revision Hip System

Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Triathlon® Cruciate Retaining (CR) Total Knee System Outcomes Study

Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease

Sunitinib Non Small Cell Lung Cancer Patients Over 70

Phase I Dose Escalation of Oral BAY1161909 in Combination With Intravenous Paclitaxel

Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance

Safety, Efficacy, Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma